BioFinance 2008
Toronto Marriott Eaton Centre Hotel - Toronto
May 7, 2008 at 9:00 a.m. EDT
Presenter: Donald F. Corcoran, President & CEO
ASCO 2008 Annual Meeting
May 31 to June 3, 2008 - Chicago
Publication: Molecular Cancer Therapeutics
MGCD0103, a novel isotype-selective HDAC inhibitor, has broad spectrum antitumor activity in vitro and in vivo
April 2008, Vol. 7, No. 4: 759-768.
Publication: Bioorganic & Medicinal Chemistry Letters
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases
18 (April 2008) 2793-2798.
Today is Friday, May 09, 2008
No Iframe !? Please download the latest version of your browser.
Our Stock Symbol:
MYG.TO
Last price:
2.50
Volume
0
Open:
2.49
High:
2.50
Low:
2.49
52 Week Range:
1.82 - 4.95
Disclaimer